Annual Total Liabilities
$8.95 M
-$606.00 K-6.34%
31 December 2023
Summary:
VYNE Therapeutics annual total liabilities is currently $8.95 million, with the most recent change of -$606.00 thousand (-6.34%) on 31 December 2023. During the last 3 years, it has fallen by -$47.30 million (-84.09%). VYNE annual total liabilities is now -92.78% below its all-time high of $123.90 million, reached on 31 December 2017.VYNE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$12.66 M
+$882.00 K+7.49%
30 September 2024
Summary:
VYNE Therapeutics quarterly total liabilities is currently $12.66 million, with the most recent change of +$882.00 thousand (+7.49%) on 30 September 2024. Over the past year, it has increased by +$4.90 million (+63.12%). VYNE quarterly total liabilities is now -89.78% below its all-time high of $123.90 million, reached on 31 December 2017.VYNE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYNE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.3% | +63.1% |
| 3 y3 years | -84.1% | -43.5% |
| 5 y5 years | -6.3% | +32.2% |
VYNE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -84.1% | at low | -43.5% | +85.2% |
| 5 y | 5 years | -84.1% | at low | -86.1% | +85.2% |
| alltime | all time | -92.8% | at low | -89.8% | +85.2% |
VYNE Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.66 M(+7.5%) |
| June 2024 | - | $11.78 M(+41.8%) |
| Mar 2024 | - | $8.31 M(-7.2%) |
| Dec 2023 | $8.95 M(-6.3%) | $8.95 M(+15.3%) |
| Sept 2023 | - | $7.76 M(+1.0%) |
| June 2023 | - | $7.69 M(-13.0%) |
| Mar 2023 | - | $8.83 M(-7.6%) |
| Dec 2022 | $9.56 M(-48.1%) | $9.56 M(+39.7%) |
| Sept 2022 | - | $6.84 M(+0.1%) |
| June 2022 | - | $6.83 M(-20.4%) |
| Mar 2022 | - | $8.59 M(-53.4%) |
| Dec 2021 | $18.41 M(-67.3%) | $18.41 M(-17.9%) |
| Sept 2021 | - | $22.43 M(-62.0%) |
| June 2021 | - | $59.09 M(+5.0%) |
| Mar 2021 | - | $56.27 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $56.25 M(+427.6%) | $56.25 M(-3.3%) |
| Sept 2020 | - | $58.17 M(-1.9%) |
| June 2020 | - | $59.31 M(-34.8%) |
| Mar 2020 | - | $91.00 M(+753.6%) |
| Dec 2019 | $10.66 M(+11.6%) | $10.66 M(+11.4%) |
| Sept 2019 | - | $9.57 M(-21.6%) |
| June 2019 | - | $12.21 M(+14.9%) |
| Mar 2019 | - | $10.63 M(+11.3%) |
| Dec 2018 | $9.55 M(-92.3%) | $9.55 M(+18.3%) |
| Sept 2018 | - | $8.07 M(-7.5%) |
| June 2018 | - | $8.73 M(-40.9%) |
| Mar 2018 | - | $14.78 M(-88.1%) |
| Dec 2017 | $123.90 M(+73.3%) | $123.90 M(+0.1%) |
| Sept 2017 | - | $123.76 M(+73.1%) |
| Dec 2016 | $71.49 M(+19.5%) | $71.49 M |
| Dec 2015 | $59.84 M | - |
FAQ
- What is VYNE Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics annual total liabilities year-on-year change?
- What is VYNE Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly total liabilities year-on-year change?
What is VYNE Therapeutics annual total liabilities?
The current annual total liabilities of VYNE is $8.95 M
What is the all time high annual total liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total liabilities is $123.90 M
What is VYNE Therapeutics annual total liabilities year-on-year change?
Over the past year, VYNE annual total liabilities has changed by -$606.00 K (-6.34%)
What is VYNE Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VYNE is $12.66 M
What is the all time high quarterly total liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total liabilities is $123.90 M
What is VYNE Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VYNE quarterly total liabilities has changed by +$4.90 M (+63.12%)